JOHN B HENNEMAN III Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN B HENNEMAN III.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN B HENNEMAN III. JOHN B HENNEMAN III is a Director in Anika Therapeutics, Inc. ($ANIK) and a Chief Administrative Officer in NEWLINK GENETICS CORP ($NLNK) and a EVP, Chief Financial Officer in NEWLINK GENETICS CORP ($NLNK) and a Director in Accretive Health, Inc. ($AH) and a Director in SeaSpine Holdings Corp ($SPNE) and a in Aprea Therapeutics, Inc. ($APRE).
Companies in which JOHN B HENNEMAN III is an Insider
Anika Therapeutics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHN B HENNEMAN III: Director
Holdings: 9,310 shares
Current Value: $468,293
Latest Transaction: Sep 08 2020
$ANIK Market Capitalization: $733.34M
$ANIK Previous Close: $50.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aprea Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN B HENNEMAN III:
Holdings: 5,000 shares
Latest Transaction: Jul 01 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LUMOS PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN B HENNEMAN III: Chief Administrative Officer, EVP, Chief Financial Officer
Holdings: 55,052 shares
Current Value: $752,561
Latest Transaction: Oct 02 2018
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
R1 RCM INC.
Industry: SERVICES-MANAGEMENT SERVICES [8741]
Position of JOHN B HENNEMAN III: Director
Holdings: 100 shares
Latest Transaction: May 24 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SeaSpine Holdings Corp
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHN B HENNEMAN III: Director
Holdings: 66,711 shares
Current Value: $467,644
Latest Transaction: Jun 04 2021
$SPNE Market Capitalization: $78.44M
$SPNE Previous Close: $7.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN B HENNEMAN III
Sentiment: All, ANIK, APRE, NLNK, AH, SPNE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | SPNE | SeaSpine Holdings ... | HENNEMAN JOHN B III | Director | Grant | A | 0.00 | 6,253 | 0 | 66,711 | 60.5 K to 66.7 K (+10.34 %) |
| May 24 2021 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 0.00 | 5,151 | 0 | 5,151 | |
| Apr 02 2021 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 24.98 | 1,490 | 37,220 | 1,490 | |
| Jan 05 2021 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 23.49 | 1,625 | 38,171 | 1,625 | |
| Oct 02 2020 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 17.54 | 2,186 | 38,342 | 2,186 | |
| Sep 08 2020 | ANIK | Anika Therapeutics ... | HENNEMAN JOHN B III | Director | Grant | A | 0.00 | 9,310 | 0 | 9,310 | 0 to 9.3 K |
| Aug 05 2020 | SPNE | SeaSpine Holdings ... | HENNEMAN JOHN B III | Director | Sell | S | 15.00 | 10,000 | 150,000 | 60,458 | 70.5 K to 60.5 K (-14.19 %) |